Dysfunctional Uterine Bleeding After Tubal Sterilization

Sponsor
Tanta University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04396483
Collaborator
(none)
220
2
2
12.9
110
8.5

Study Details

Study Description

Brief Summary

In this study, the investigators will compare the frequency and amount of bleeding after tubal sterilization and salpingectomy

Condition or Disease Intervention/Treatment Phase
  • Procedure: Pomeroy's tubal sterilization
  • Procedure: Salpingectomy
N/A

Detailed Description

Dysfunctional uterine bleeding is common after tubal sterilization.

The investigators will compare the frequency and amount of bleeding after two techniques eithe tubal sterilization by pomeroy's method during cesarean section or complete salpingectomy

Study Design

Study Type:
Interventional
Anticipated Enrollment :
220 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Investigator, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Dysfunctional Uterine Bleeding After Tubal Sterilization and Salpingectomy
Actual Study Start Date :
Jun 1, 2021
Anticipated Primary Completion Date :
Jun 30, 2022
Anticipated Study Completion Date :
Jun 30, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Tubal sterilization "Pomeroy's method"

Procedure: Pomeroy's tubal sterilization
Both Fallopian tubes will be grasped by allis forceps and a kokher forceps will be applied below the allis forceps then excision of tubal part above kokher and transfixation of both ends away from each other during cesarean section

Active Comparator: Salpingectomy

Procedure: Salpingectomy
Both fallopian tubes will be completely removed during cesarean section

Outcome Measures

Primary Outcome Measures

  1. Frequency of Dysfunctional bleeding [1 year after cesarean section]

    percentage of cases suffering of dysfunctional bleeding

  2. Amount of bleeding [1 year after cesarean section]

    number of sanitary pads during bleeding

Eligibility Criteria

Criteria

Ages Eligible for Study:
20 Years to 40 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Age 20-40

  • Patient completed her family

  • Patient on cesarean delivery

Exclusion Criteria:
  • Tubal sterilization by other methods

  • Salpingectomy by laparoscopy

  • Patient wishing fertility

Contacts and Locations

Locations

Site City State Country Postal Code
1 Adel Elgergawy Tanta Gharbia Egypt 31111
2 Ayman Shehata Dawood Tanta Gharbia Egypt 31111

Sponsors and Collaborators

  • Tanta University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Ayman S Dawood, MD, Principal investigator, Tanta University
ClinicalTrials.gov Identifier:
NCT04396483
Other Study ID Numbers:
  • DUBATS
First Posted:
May 20, 2020
Last Update Posted:
Jun 16, 2021
Last Verified:
Jun 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Ayman S Dawood, MD, Principal investigator, Tanta University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 16, 2021